HIMS has seen a drop in its stock price as it navigates a competitive landscape marked by intensified efforts from companies like Lilly and WeightWatchers.
The CEO of HIMS has expressed optimism about the potential of AI advancements, particularly those from Anthropic, to enhance healthcare services.
As the market evolves, HIMS appears to be focusing on integrating AI technologies to maintain relevance and address the challenges posed by its competitors.